Patent
The present invention relates to a method for treating a sleep disorder. Preferably, the invention relates to a method for treating a sleep disorder comprising the step of administering a pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a terpene fraction comprising limonene in an amount of at least about 5.4% by weight of the terpene fraction.
1. A pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising:
Δ 9 -Tetrahydrocannabinol (THC) in an amount of from 50% to 90% by weight of the Cannabis extract;
Cannabidiol (CBD) in an amount of up to 10% by weight of the Cannabis extract;
Cannabinol (CBN) in an amount of up to 10% by weight of the Cannabis extract; and
a terpene fraction in an amount of more than 1% by weight of the Cannabis extract, the terpene fraction comprising:
a nerolidol being absent or in an amount of from about 0.01% to about 20% by weight of the terpene fraction;
beta-myrcene in an amount of up to 40% by weight of the terpene fraction;
linalool in an amount of at least 5% by weight of the terpene fraction;
alpha-pinene in an amount of from 0.001% to 20% by weight of the terpene fraction; and
beta-pinene in an amount of from 0.001% to 80% by weight of the terpene fraction.
2. The pharmaceutical composition of claim 1 , wherein the Cannabis extract comprises THC in an amount from 55 to 85% by weight of the extract.
3. The pharmaceutical composition of claim 1 , wherein the Cannabis extract comprises Δ 9 -Tetrahydrocannabivarin (THCV) in an amount from 0.001% to 10% by weight of the extract.
4. The pharmaceutical composition of claim 1 , wherein the terpene fraction comprises beta-pinene in an amount of at least 5% by weight of the terpene fraction.
5. The pharmaceutical composition of claim 1 , wherein the terpene fraction comprises alpha-pinene in an amount of from about 0.001% to 20% by weight of the terpene fraction.
6. The pharmaceutical composition of claim 5 , wherein the terpene fraction comprises alpha-pinene in an amount of at least 5% by weight of the terpene fraction.
7. The pharmaceutical composition of claim 1 , wherein the terpene fraction comprises a nerolidol in an amount of from about 0.01% to about 20% by weight of the terpene fraction.
8. The pharmaceutical composition of claim 1 , wherein the terpene fraction is present in an amount of up to 10% by weight of the Cannabis extract.
9. The pharmaceutical composition of claim 1 , wherein
the Cannabis extract comprises:
THC in an amount from 55 to 85% by weight of the extract;
CBD in an amount from 0.001% to 10% by weight of the extract;
CBN in an amount from 0.001% to 10% by weight of the extract;
THCV in an amount from 0.001% to 10% by weight of the extract;
the terpene fraction is present in an amount of up to 10% by weight of the Cannabis extract, and the terpene fraction comprises:
beta-pinene in an amount of at least 5% by weight of the terpene fraction;
alpha-pinene in an amount of from about 0.001% to 20% by weight of the terpene fraction;
beta-myrcene in an amount of up to about 40% by weight of the terpene fraction; and
a nerolidol in an amount of from about 0.01% to about 20% by weight of the terpene fraction.
10. The pharmaceutical composition of claim 1 , for treating a sleep disorder.